Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J1AW
|
||||
| Former ID |
DNC008209
|
||||
| Drug Name |
4-(3-hydroxy-benzylideneamino)-benzenesulfonamide
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529203] | ||
| Formula |
C13H12N2O3S
|
||||
| Canonical SMILES |
C1=CC(=CC(=C1)O)C=NC2=CC=C(C=C2)S(=O)(=O)N
|
||||
| InChI |
1S/C13H12N2O3S/c14-19(17,18)13-6-4-11(5-7-13)15-9-10-2-1-3-12(16)8-10/h1-9,16H,(H2,14,17,18)
|
||||
| InChIKey |
FNUVWCBUDJAFOI-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Prostaglandin G/H synthase 2 | Target Info | Inhibitor | [529203] | |
| KEGG Pathway | Arachidonic acid metabolism | ||||
| Metabolic pathways | |||||
| NF-kappa B signaling pathway | |||||
| VEGF signaling pathway | |||||
| TNF signaling pathway | |||||
| Retrograde endocannabinoid signaling | |||||
| Serotonergic synapse | |||||
| Ovarian steroidogenesis | |||||
| Oxytocin signaling pathway | |||||
| Regulation of lipolysis in adipocytes | |||||
| Leishmaniasis | |||||
| Pathways in cancer | |||||
| Chemical carcinogenesis | |||||
| MicroRNAs in cancer | |||||
| Small cell lung cancer | |||||
| PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.